Bookmark

Add to MyYahoo RSS

Jazz Pharmaceuticals News

News on Jazz Pharmaceuticals (Ticker: JAZZ) continually updated from thousands of sources around the net.

6 hrs ago | Investor's Business Daily

Jazz Pharma Bounces Back After Triggering Sell Signal

Just because a stock triggers a sell signal after a breakout doesn't mean you should completely write it off.

Comment?

Related Topix: Startups

12 hrs ago | Sys-Con Media

Box Powers Cloud Collaboration for Leading Life Sciences Organizations

Box today announced that leading pharmaceutical and life sciences organizations Jazz Pharmaceuticals and Boston Scientific Corporation have recently chosen Box as their primary platform for managing and collaborating on content.

Comment?

Related Topix: Startups, Medicine, Boston Scientific, Medical Equipment, Healthcare Industry, Sales, CIO News

16 hrs ago | Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

The fundraising event benefits The 30-Days Foundation, a ... )--Narrative Science, the leader in Narrative Analytics, today announced Narrative Science co-founder and Chief Scientist Kris Hammond, Ph.D., will present "The Future of Com... )--Box today announced that leading pharmaceutical and life sciences organizations Jazz Pharmaceuticals and ... (more)

Comment?

Related Topix: Inventions, Science / Technology, Monsanto, Chemicals, August, CA, Startups

Tue Aug 19, 2014

AmericanBankingNews.com

Jazz Pharmaceuticals plc - Research Coverage Started at JPMorgan Chase & Co.

The firm set an "overweight" rating and a $190.00 price target on the stock. JPMorgan Chase & Co.'

Comment?

Related Topix: Startups, Banking, JP Morgan Chase

Wed Aug 13, 2014

AmericanBankingNews.com

Insider Selling: Jazz Pharmaceuticals plc - CEO Sells 5,000 Shares of Stock

Jazz Pharmaceuticals plc - CEO Bruce C. Cozadd sold 5,000 shares of the company's stock in a transaction dated Tuesday, August 12th.

Comment?

Related Topix: Startups

Reuters

Us Stocks-Wall Street rises, biotech shares lead rally

U.S. stocks rose on Wednesday, with the Dow returning to positive territory for the year as the market shrugged off weak earnings reports and a slump in retail shares.

Comment?

Related Topix: Financial Markets, Startups

Sun Aug 10, 2014

AmericanBankingNews.com

Jazz Pharmaceuticals plc - Given Average Recommendation of "Buy" by Analysts

Jazz Pharmaceuticals plc - has received an average rating of "Buy" from the twenty-two analysts that are currently covering the company, Analyst Ratings.Net reports .

Comment?

Related Topix: Startups

Thu Aug 07, 2014

BioSpace

Jazz Pharmaceuticals plc Announces Proposed Offering Of $500 Million...

In connection with the offering, the Issuer expects to grant the initial purchasers an option to purchase up to an additional The notes will be exchangeable under certain circumstances for cash, ordinary shares of Jazz Pharmaceuticals plc , or a combination thereof, based on an exchange rate to be determined.

Comment?

Related Topix: Startups, Corporate / Securities Law, Law

Tue Aug 05, 2014

Drugs.com

Jazz Pharmaceuticals Completes Acquisition Of Rights To Defibrotide

Jazz Pharmaceuticals plc today announced the closing of its acquisition of rights to defibrotide in the United States and all other countries in the Americas from Sigma-Tau Pharmaceuticals, Inc. .

Comment?

Related Topix: Startups, Stem Cell Research, Science / Technology, Food and Drug Administration, Oncology

Mon Aug 04, 2014

Freshnews

Jazz Pharmaceuticals Announces Participation at Canaccord Genuity Conference on August 13

Jazz Pharmaceuticals plc today announced that the company will be webcasting its corporate presentation at the Canaccord Genuity 34 Annual Growth Conference in Boston, MA on Wednesday, August 13, 2014 at 9:00 a.m. EDT / 2:00 p.m. IST.

Comment?

Related Topix: Startups

Wed Jul 30, 2014

AmericanBankingNews.com

Jazz Pharmaceuticals plc - Shares Gap Up Following Analyst Upgrade

Shares of Jazz Pharmaceuticals plc - gapped up prior to trading on Wednesday after Leerink Swann raised their price target on the stock from $171.00 to $177.00, AnalystRatingsNetwork reports.

Comment?

Related Topix: Startups

Mon Jul 28, 2014

BioSpace

CANbridge Life Sciences And EUSA Pharma Form Agreement To Commericalize Caphosol In China

CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug candidates in China and North Asia, has entered into an exclusive partnership with EUSA Pharma, a Jazz Pharmaceuticals company , to commercialize CaphosolA in China.

Comment?

Related Topix: Startups

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

With thi... Double Crown Resources Reports on Initial Shipment of High Grade Barite to 1st Customer Prior to Long Term Monthly Supply Contract )--July 28, 2014 -- Double Crown Resources, Inc. , a fully reporting company, would like to provide an update on recent prog... )--Novinda has a new product designed to provide low cost oxidation of vapor ... (more)

Comment?

Related Topix: Startups, NCR, Computers, Antonio, Alternative

Tue Jul 22, 2014

BioSpace

Jazz Pharmaceuticals plc To Report 2014 Second Quarter Financial Results On August 5, 2014

Company management will host a live audio webcast immediately following the announcement at Interested parties may access the live audio webcast via the Investors & Media section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com .

Comment?

Related Topix: Startups

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••